As advanced therapies and vaccines reshape healthcare, Wacker ­Biotech is emerging as a CDMO partner of choice. With decades ...

French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront acquisition of Edgewise Therapeutics' muscular dystrophy business.

Swedish biotech Alligator Bioscience has agreed to sell its CD40-targeting cancer immunotherapy mitazalimab to Canadian drug ...

The Basel region is one of the world’s leading life-science clusters. ­Pharmaceutical companies, biotech firms and research ...

Denmark's Genmab said adding its bispecific antibody petosemtamab to MSD's Keytruda (pembrolizumab) cut the risk of death by ...

Fresenius has secured options on 37 biosimilars from WuXi Biologics, significantly expanding its biopharma ambitions through a development agreement. The deal comes as numerous high-selling biologics ...

Spanish biotech ALLOX has closed a €9.4 million ($10.5 million) seed round, led by Asabys with participation from Spanish and ...

Swiss DARPin specialist Molecular Partners is shifting its entire focus to radiopharmaceuticals and plans to cut up to 55 ...

Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...

From Berlin biotech NOXXON through a strategic realignment and considerations of cryptocurrency investments, and now back to ...

Portugal-based Exogenus Therapeutics will lead a five-year, €13 million Horizon Europe project to advance its osteoarthritis ...